Hypoxia Promotes 786-O Cells Invasiveness and Resistance to Sorafenib Via HIF-2α/COX-2

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2014 Dec 10

PMID 25487445

Citations 21

Authors

Chun-Xiong Zhao

Chun-Li Luo

Xiao-Hou Wu

Affiliations

Soon will be listed here.

Abstract

Accumulating evidences indicated that hypoxia-induced factors and COX-2 play a important role in tumorigenesis in various human cancer. Yet, the relationship between HIFs and COX-2 in human renal cancer remains unclear. The present study was to examine the role of HIFs and COX-2 in the invasiveness and the resistance to target agent in renal cancer cell line (786-O). In 786-O cells, hypoxia induced the increase in the protein expression of HIF1 and HIF2. We also demonstrate that hypoxia up-regulated the protein expression of COX-2 and Snail, but down-regulation of E-cadherin expression in 786-O cells promoted the invasiveness of 786-O cells and enhanced the resistance of 786-O cells to sorafenib. siRNA target to HIF1α, HIF2α and NS398, a selective inhibitor of COX-2, were used in this study. Only siRNA-HIF2α significantly suppressed the protein expression of HIF2 and COX-2, then decreased the invasive ability and resistance of 786-O cells to sorafenib under hypoxia. NS398 attenuated the increase in invasive cells number and the IC50 value of sorafenib induced by hypoxia. In conclusion, our results demonstrated that hypoxia promoted the invasiveness and resistance of 786-O cells to sorafenib via HIF2 and COX-2 and induced the activation of Snail/E-cadherin, suggesting that a signalling mechanism involving HIF2/COX2 modulates invasiveness and resistance to sorafenib in 786-O cells under hypoxia.

Citing Articles

Evidence for Functional Regulation of the KLHL3/WNK Pathway by O-GlcNAcylation.

Hu J, Huynh D, Dunn D, Wu J, Manriquez-Rodriguez C, Zhang Q bioRxiv. 2025; .

PMID: 40060460 PMC: 11888436. DOI: 10.1101/2025.02.27.640596.

Effects of hypoxia stress on the milk synthesis in bovine mammary epithelial cells.

Jin Y, Liu Z, Yang Z, Fang L, Zhao F, Liu H J Anim Sci Biotechnol. 2025; 16(1):37.

PMID: 40050971 PMC: 11887346. DOI: 10.1186/s40104-025-01174-0.

Dense Collagen I as a Biomimetic Material to Track Matrix Remodelling in Renal Carcinomas.

Upadhyay A, Bakkalci D, Micalet A, Butler M, Bergin M, Moeendarbary E ACS Omega. 2024; 9(40):41419-41432.

PMID: 39398183 PMC: 11465592. DOI: 10.1021/acsomega.4c04442.

Integrating tumor and healthy epithelium in a micro-physiology multi-compartment approach to study renal cell carcinoma pathophysiology.

Somova M, Simm S, Padmyastuti A, Ehrhardt J, Schoon J, Wolff I Sci Rep. 2024; 14(1):9357.

PMID: 38653823 PMC: 11039668. DOI: 10.1038/s41598-024-60164-w.

Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions.

Chen Z, Han F, Du Y, Shi H, Zhou W Signal Transduct Target Ther. 2023; 8(1):70.

PMID: 36797231 PMC: 9935926. DOI: 10.1038/s41392-023-01332-8.

References

Wu H, Liang X, Fang Y, Qin X, Zhang Y, Liu J . Resveratrol inhibits hypoxia-induced metastasis potential enhancement by restricting hypoxia-induced factor-1 alpha expression in colon carcinoma cells. Biomed Pharmacother. 2008; 62(9):613-21. DOI: 10.1016/j.biopha.2008.06.036. View

Bocca C, Ievolella M, Autelli R, Motta M, Mosso L, Torchio B . Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness. Expert Opin Ther Targets. 2013; 18(2):121-35. DOI: 10.1517/14728222.2014.860447. View

Scholten 2nd D, Timmer C, Peacock J, Pelle D, Williams B, Steensma M . Down regulation of Wnt signaling mitigates hypoxia-induced chemoresistance in human osteosarcoma cells. PLoS One. 2014; 9(10):e111431. PMC: 4210185. DOI: 10.1371/journal.pone.0111431. View

Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou P . Interaction with Suv39H1 is critical for Snail-mediated E-cadherin repression in breast cancer. Oncogene. 2012; 32(11):1351-62. PMC: 3703513. DOI: 10.1038/onc.2012.169. View

Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou P . G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer. J Clin Invest. 2012; 122(4):1469-86. PMC: 3314447. DOI: 10.1172/JCI57349. View

Fong G, Takeda K . Role and regulation of prolyl hydroxylase domain proteins. Cell Death Differ. 2008; 15(4):635-41. DOI: 10.1038/cdd.2008.10. View

Johansson A, Rudolfsson S, Kilter S, Bergh A . Targeting castration-induced tumour hypoxia enhances the acute effects of castration therapy in a rat prostate cancer model. BJU Int. 2010; 107(11):1818-24. DOI: 10.1111/j.1464-410X.2010.09690.x. View

Song X, Liu X, Chi W, Liu Y, Wei L, Wang X . Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene. Cancer Chemother Pharmacol. 2006; 58(6):776-84. DOI: 10.1007/s00280-006-0224-7. View

Sena J, Wang L, Hu C . BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes. Mol Cell Biol. 2013; 33(19):3849-63. PMC: 3811865. DOI: 10.1128/MCB.00731-13. View

10.

Cui J, Guo Y, Zhang H, Jiang L, Ma J, Wang W . Cyclooxygenase-2 inhibitor is a robust enhancer of anticancer agents against hepatocellular carcinoma multicellular spheroids. Onco Targets Ther. 2014; 7:353-63. PMC: 3938498. DOI: 10.2147/OTT.S56115. View

11.

Kalluri R, Weinberg R . The basics of epithelial-mesenchymal transition. J Clin Invest. 2009; 119(6):1420-8. PMC: 2689101. DOI: 10.1172/JCI39104. View

12.

Hou Z, Peng H, Ayyanathan K, Yan K, Langer E, Longmore G . The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol. 2008; 28(10):3198-207. PMC: 2423142. DOI: 10.1128/MCB.01435-07. View

13.

Rini B, Campbell S, Escudier B . Renal cell carcinoma. Lancet. 2009; 373(9669):1119-32. DOI: 10.1016/S0140-6736(09)60229-4. View

14.

Wang X, Zhang L, ONeill A, Bahamon B, Alsop D, Mier J . Cox-2 inhibition enhances the activity of sunitinib in human renal cell carcinoma xenografts. Br J Cancer. 2013; 108(2):319-26. PMC: 3566808. DOI: 10.1038/bjc.2012.591. View

15.

Franovic A, Gunaratnam L, Smith K, Robert I, Patten D, Lee S . Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer. Proc Natl Acad Sci U S A. 2007; 104(32):13092-7. PMC: 1941796. DOI: 10.1073/pnas.0702387104. View

16.

Kirkpatrick K, Ogunkolade W, Elkak A, Bustin S, Jenkins P, Ghilchik M . The mRNA expression of cyclo-oxygenase-2 (COX-2) and vascular endothelial growth factor (VEGF) in human breast cancer. Curr Med Res Opin. 2002; 18(4):237-41. DOI: 10.1185/030079902125000633. View

17.

Cunha L, Marcello M, Nonogaki S, Morari E, Soares F, Vassallo J . CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancer. Clin Endocrinol (Oxf). 2014; 83(2):246-53. DOI: 10.1111/cen.12586. View

18.

Wiesener M, Turley H, Allen W, Willam C, Eckardt K, Talks K . Induction of endothelial PAS domain protein-1 by hypoxia: characterization and comparison with hypoxia-inducible factor-1alpha. Blood. 1998; 92(7):2260-8. View

19.

McLaughlin J, Lipworth L . Epidemiologic aspects of renal cell cancer. Semin Oncol. 2000; 27(2):115-23. View

20.

Kondo K, Klco J, Nakamura E, Lechpammer M, Kaelin Jr W . Inhibition of HIF is necessary for tumor suppression by the von Hippel-Lindau protein. Cancer Cell. 2002; 1(3):237-46. DOI: 10.1016/s1535-6108(02)00043-0. View